Biota Pharmaceuticals IncAdd to My Watchlist

BOTA:USNASDAQ GSIndustry: Medical-Biomedical/Gene
  • 2.11
  • 0.02  -0.94%
    Today's Change
  • 2.13
    Previous Close
  • Today
    52 Week Low - High
8:10 pm ET 10/8/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding39 million
Market Cap$81 million
Return on Equity ttm-24.42%
Last Dividend$6.65
Dividend Yield ttm--
Relative Dividend Yield benchmark--
Dividend Ex-Date11/9/12
Dividend Pay Date11/8/12
EPS: Year Actual ttm-0.210
EPS: Year Est. 6/16 ttm--
EPS: Quarterly Actual 6/15 --
EPS: Quarterly Est. -- --
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-54.29
Company Description
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Revenue$25 million
Net Income$-19 million
Total Assets$79 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!